Global Biolabs founders Filippa Lentzos and Gregory Koblentz have written extensively for authoritative publications about efforts to improve biorisk management around the world. Some of their work can be found below.
Articles
A plan B to strengthen biosafety and biosecurity
Koblentz, Gregory D. & Filippa Lentzos (2022), Council on Foreign Relations: Think Global Health, 15 November.
The urgent need for an overhaul of global biorisk management
Filippa Lentzos, Gregory D. Koblentz and Joseph Rodgers (2022), West Point CTC Sentinel Vol.15(4): 23-29.
Have hybrid coronaviruses already been made? We simply don’t know for sure, and that’s a problem
Filippa Lentzos & Gregory D. Koblentz (2022), The Conversation, 21 Feb.
How to make sure the labs researching the most dangerous pathogens are safe and secure
Rodgers, Joseph, Filippa Lentzos, Gregory D. Koblentz & Minh Ly (2021), The Bulletin of Atomic Scientists, 2 July.
Whether Covid came from a leak or not, it’s time to talk about lab safety
Koblentz, Gregory D. & Filippa Lentzos (2021), The Guardian, 15 June.
Fifty-nine labs around world handle the deadliest pathogens – only a quarter score high on safety
Lentzos, Filippa & Gregory D. Koblentz (2021), The Conversation, 14 June.
